Riskpilot← Back to searchSign inGet full accessVarholmen Utveckling AB
ABIn liquidationOrg 5568801160Kurt Hellbergs Gata 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20120 employees
Revenue 2025
SEK 0
EBITDA margin
—
-200% vs 2024
Equity ratio
11.8%
Financial strength
Net profit 2025
SEK 20K
+900% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | -200% |
| Net profit | SEK 20K | +900% |
| Total assets | SEK 457K | +0% |
| Equity | SEK 54K | +54% |
| Employees | 0 | — |
Legal name
Varholmen Utveckling AB
Org number
5568801160
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9 januari 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva import och export, samt försäljning av fiskeutrustning, produktutveckling av fiskeutrustning, webdesign, försäljning av tjänster inom certifiering, konsultverksamhet inom teknik och utveckling, fastighetsförvaltning, samt handel med värdepapper.
Address
Kurt Hellbergs Gata 4
Email
ake@dalekab.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 251 | 147 | 196 | 20 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 56 | 6 | −111 | 2 | −2 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 56 | 6 | −111 | 2 | −2 |
| Net financials | — | 2 | — | — | 22 |
| Profit before tax | 56 | 8 | −111 | 2 | 20 |
| Tax | −11 | −2 | −0 | −0 | −0 |
| Net profit | 45 | 6 | −111 | 2 | 20 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 577 | 574 | 461 | 459 | 457 |
| Equity | 138 | 144 | 32 | 35 | 54 |
| Long-term debt | 415 | 421 | 421 | 419 | 403 |
| Short-term debt | 24 | 10 | 7 | 5 | 0 |
| Total debt | 439 | 431 | 428 | 424 | 403 |
EBITDA margin
-200000.0%
This company
15.8%
Market median
-1265923% vs market
20212025
Equity ratio
11.8%
This company
38.2%
Market median
-69% vs market
20212025
Return on equity
37.0%
This company
18.4%
Market median
+101% vs market
20212025
Net profit margin
2000000.0%
This company
8.1%
Market median
+24691258% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
7.46×
This company
0.62×
Market median
-1103% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ÅV Liquidator | Liquidator | 2025 |
| Former (1) | ||
ÅO Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Chairman | 2020 – 2025 | |
| Deputy Board Member | 2020 – 2025 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Varholmen Utveckling AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Åke Olof Karlsson | Deputy Chief Executive Officer | 0 companies |
| Åke Vilhelm Callh | Liquidator | 0 companies |
| Håkan Eric Kristiansen | Chairman | 0 companies |
| Delara Valizadeh Karlsson | Deputy Board Member | 0 companies |
| Elin Carolina Dahlgren | Deputy Board Member | 0 companies |